In Brief Van Andel Research Institute-SU2C Dream Team trial enters phase II February 05, 2016Vol.42 No.05
Capitol Hill FDA Releases New Opioid Plan as Senators Stall Robert Califf’s Confirmation as Commissioner February 05, 2016Vol.42 No.05By Conor Hale
Drugs & Targets Opdivo-Yervoy Combination Granted Accelerated Approval in Metastatic Melanoma February 01, 2016Vol.39 No.01
Analysis Evaluates Moore Criteria for Bevacizumab Effectiveness in Cervical Cancer February 01, 2016Vol.39 No.01
Vectibix Meets Primary Endpoint In Phase III Wild-Type KRAS Colorectal Cancer Trial February 01, 2016Vol.39 No.01
